A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Active, not recruiting · NCT06770933 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01 | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Active, not recruiting | Phase 2 | 2026-10-02 | NCT06770933 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vantage Biosciences Australia Pty Ltd | 1 |
| Vantage Biosciences Ltd | 1 |
27 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.